Cargando…

Commentary: Use of biosimilars for retinal diseases in India: Challenges and concerns

Detalles Bibliográficos
Autores principales:	Kumar, Aman, Agarwal, Divya, Kumar, Atul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933877/ https://www.ncbi.nlm.nih.gov/pubmed/33463591 http://dx.doi.org/10.4103/ijo.IJO_39_21

Ejemplares similares

Commentary: Understanding diabetic retinopathy trends in India: Lessons learnt and future implications
por: Agarwal, Divya, et al.
Publicado: (2021)

Commentary: Teleophthalmology in India: Hybrid approach will be a game changer in the COVID-19 Era
por: Agarwal, Divya, et al.
Publicado: (2021)

Commentary: Training optometrists and allied ophthalmic personnel: Expanding horizon of diabetic retinopathy screening in India
por: Agarwal, Divya, et al.
Publicado: (2021)

Commentary: Targeted high-risk screening for diabetic retinopathy in India: Feasible short-term strategy
por: Agarwal, Divya, et al.
Publicado: (2021)

Commentary: Coats disease: Our experience in India
por: Kumar, Atul, et al.
Publicado: (2019)

Commentary: Medico legal aspects in ophthalmology in India
por: Agarwal, Divya, et al.
Publicado: (2019)

Commentary: Managing treatment-resistant polypoidal choroidal vasculopathy – Evolving concepts
por: Agarwal, Divya, et al.
Publicado: (2022)

Commentary: Artificial intelligence in ophthalmology: Potential challenges and way ahead
por: Agarwal, Divya, et al.
Publicado: (2020)

Commentary: Learning curve of a trained vitreo-retinal surgeon in sub-retinal injections in a rat model: Implications for future clinical trials
por: Kumar, Atul, et al.
Publicado: (2019)

Commentary: A cluster of central retinal artery occlusions following cataract surgery
por: Kumar, Atul, et al.
Publicado: (2019)

Commentary: Restructuring residency training in ophthalmology during COVID-19 era: Challenges and opportunities
por: Kumar, Atul, et al.
Publicado: (2020)

Commentary: Role of antibiotics in cataract surgery
por: Agarwal, Divya, et al.
Publicado: (2020)

Commentary: Role of sterile air in ophthalmic surgery operation theater
por: Agarwal, Divya, et al.
Publicado: (2020)

Commentary: Improving training in retina in Indian residency programmes
por: Kumar, Atul, et al.
Publicado: (2019)

Commentary: Intracameral antibiotic reduces the risk of post-cataract surgery endophthalmitis but does not eliminate it
por: Agarwal, Divya, et al.
Publicado: (2020)

Commentary: Considerations regarding area of internal limiting membrane peeling during macular hole surgery
por: Kumar, Atul, et al.
Publicado: (2020)

Commentary: Electronic medical record system – should complement but not replace traditional health care
por: Kumar, Atul, et al.
Publicado: (2020)

Diabetic retinopathy screening and management in India: Challenges and possible solutions
por: Kumar, Atul, et al.
Publicado: (2021)

Commentary: Pars plana vitrectomy for acute retinal necrosis related rhegmatogenous retinal detachment
por: Kumar, Atul, et al.
Publicado: (2021)

Commentary: Biosimilars in the treatment of retinopathy of prematurity
por: Soni, Tanvi, et al.
Publicado: (2023)

Abuse of topical corticosteroids in India: Concerns and the way forward
por: Kumar, Subodh, et al.
Publicado: (2016)

Commentary: Decoding genetic retinal diseases research in India
por: Parameswarappa, Deepika C, et al.
Publicado: (2022)

Commentary: An insight into the preferred practice of vitreoretinal specialists of India: Medical retina
por: Kumar, Atul, et al.
Publicado: (2021)

Commentary: An insight into the preferred practice of vitreoretinal specialists of India: Surgical retina
por: Kumar, Atul, et al.
Publicado: (2021)

Commentary: The challenges of treating retinoblastoma in India
por: Shah, Parag K
Publicado: (2019)

Commentary: Visual impairment due to retinitis pigmentosa in India
por: Battu, Rajani
Publicado: (2023)

Commentary: Teleconsultation at a tertiary care set-up during COVID-19 lockdown in India
por: Kumar, Atul, et al.
Publicado: (2020)

Commentary: From diabetic retinopathy toward diabetic retinal disease
por: Saurabh, Kumar, et al.
Publicado: (2021)

Commentary on “Community care for diabetic retinopathy and glaucoma in India: A panel discussion”
por: Kumar, Atul, et al.
Publicado: (2018)

Commentary: Diagnostic challenges in sarcoid uveitis in India
por: Biswas, Jyotirmay, et al.
Publicado: (2022)

Commentary: Thyroid eye disease—does the profile differ in India?
por: Grover, Ashok Kumar
Publicado: (2020)

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
por: Steinberg, Judith, et al.
Publicado: (2019)

The dire need for primary care specialization in India: Concerns and challenges
por: Faizi, Nafis, et al.
Publicado: (2016)

Commentary: Fibrin glue in rhegmatogenous retinal detachment repair—Are we there yet?
por: Anshuman, Kumar, et al.
Publicado: (2019)

Commentary: Surgical challenges associated with the management of retinal detachment associated with chorioretinal coloboma
por: Babu, Naresh, et al.
Publicado: (2022)

Commentary: The changing scenario of cluster endophthalmitis
por: Kumar, Atul, et al.
Publicado: (2018)

Commentary: Significance of early screening for color vision in children
por: Singh, Atul Kumar, et al.
Publicado: (2021)

Commentary: Primary angle-closure disease in retinitis pigmentosa
por: Venkatesh, Rengaraj, et al.
Publicado: (2022)

Commentary: Cause for concern or 1 in 33 million?
por: Paone, Gaetano
Publicado: (2020)

Commentary: Anti-vascular endothelial growth factor therapies in vitreo-retina practice: Biosimilars versus biologics
por: Anantharaman, Giridhar
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_929dnk8i335hi3hfhhbqldu906